GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (FRA:GU5) » Definitions » Net Income (Continuing Operations)

Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Net Income (Continuing Operations) : €463 Mil (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was €79 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was €463 Mil.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Net Income (Continuing Operations) Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Net Income (Continuing Operations) Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 441.59 388.62 551.48 575.93 547.02

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.29 42.46 259.56 81.48 79.13

Guangzhou Baiyunshan Pharmaceutical Holdings Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €463 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (FRA:GU5) » Definitions » Net Income (Continuing Operations)
Comparable Companies
SHSE:600511 SHSE:600056 SHSE:600739 SZSE:000028 SHSE:601607 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 MCK COR CAH HSIC HKSE:01099 MIL:AMP XSWX:GALE NZSE:EBO TSE:7459 TSE:2784 ASX:SIG
Traded in Other Exchanges
00874:Hong Kong 600332:China
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Website
https://www.gybys.com.cn
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Headlines

No Headlines